Matthieu Duchmann

13PUBLICATIONS
123CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Gene and molecular therapyHaematological tumoursMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Sep 09, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.

Michael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard

|Apr 18, 2025
Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine.

Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette

|Feb 20, 2024
Germline CHEK2 mutations in patients with myeloid neoplasms.

Lucie Freiman, Lise Larcher, Giulia Tueur

|Feb 17, 2024
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.

Marie Sébert, Lucie Freiman, Cendrine Chaffaut

|Jan 11, 2023
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.

Rathana Kim, Hugo Bergugnat, Lise Larcher

Pageof 3

Frequent Collaborators

10 joint publications

Lionel Adès

8 joint publications

Raphael Itzykson

6 joint publications

Nicolas Duployez

5 joint publications

Rathana Kim